Dr. Jan-Dirk Spöring represented Ypso-Facto at the ISPE event “Current trends in biomanufacturing”, where experts explored how the biopharma landscape in Germany continues to evolve.
The discussions highlighted key production trends, with a particular focus on digital approaches ranging from data-driven methods to mechanistic modelling.
One important takeaway stood out: biotechnology and biopharma are continuing to reinforce their role as strategic industries for Germany’s future competitiveness. The dialogue with experts from academia, regulatory bodies, and industry also underlined the strong potential that emerges when these stakeholders work together.
At Ypso-Facto, we look forward to continuing the conversation and to contributing to the growth of this dynamic ecosystem.